Scandinavian Biopharma welcomes Christine Hägglund to the position as VP CMC Development
Scandinavian Biopharma is pleased to inform that Christine Hägglund has been recruited as Scandinavian Biopharmas VP CMC Development. Christine holds a PhD in Biochemistry and has almost 20 years of experience in drug development of biological pharmaceuticals. Most recently, she comes from the position of Director of Analytical Science & Technology at Sobi.
“I really look forward to the challenges that this fast-growing company will offer. It will be fun to lead and develop the CMC and analysis operations together with my experienced team. It is very motivating to be involved in the development of this unique vaccine candidate that is in late clinical phase. If we succeed, this vaccine will really be able to make a global difference. Especially for the younger children in low- and middle-income countries,” says Christine Hägglund.